ConvaVAC Ag+ NPWT for Venous Leg Ulcers
Official title: A Study to Determine the Safety and Performance of ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds
Run by ConvaTec Inc. · NCT07342049 · Data updated 2026-11-12
This trial tests whether the ConvaVAC Ag+ Negative Pressure Wound Therapy system can safely help heal venous leg ulcers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 87 (estimated) |
| Sponsor | ConvaTec Inc. Industry-sponsored |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 7 sites (Santiago, Santiago Metropolitan and 6 other locations) |
| Status | Recruiting |
| Started | January 12, 2026 |
| Main results expected | October 30, 2026 |
| Study ends | October 30, 2026 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT07342049 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with venous leg ulcers that can be treated with NPWT, with at least one sign of infection, and without contraindicating conditions.
✕Probably not a fit
Patients with wounds outside the specified size or depth range, without infection, or with contraindicating conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study investigates the safety and effectiveness of the ConvaVAC Ag+ NPWT system in treating chronic venous leg ulcers. Eligible participants are adults with VLUs that are amenable to negative pressure therapy and show signs of infection. Wounds will be managed with the ConvaVAC device to assess healing outcomes and potential reductions in infection risk. The study emphasizes chronic wounds’ burden on patients and healthcare systems and aims to determine whether this therapy offers a meaningful benefit in healing time and wound quality.
Why it matters
Potential benefit: If successful, participants may experience faster wound healing and reduced infection, potentially improving symptoms and quality of life.
How similar studies have gone: Prior evidence suggests that silver-containing NPWT approaches can help manage infected chronic wounds, though results vary by wound type and patient.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A wound which is amenable to NPWT and is a VLU as defined by CEAP Classification of C6 or C6R * Wounds that are clean or contaminated * Wounds with at least one sign or symptom of infection * Wounds that in the opinion of the investigator would benefit from an antimicrobial dressing * ≥18 years old at the time of consent Exclusion Criteria: * Known sensitivities or allergies to components of the ConvaVAC™ Ag+ NPWT System * Ischemic wounds with necrotic tissue or eschar present that require sharp debridement * Wound is too small or too large based on wound dressing size (\> 0.5cm2 and \< 100cm2) * Wound depth \>7cm * Wounds requiring concomitant use of DuoDERM® gel, hydrogels, petroleum-based creams/ ointment-/gels per the opinion of the investigator * Active chemotherapy, radiation therapy, or immunotherapy for cancer or completed treatment within the last 3 months * Any active malignancy at site of dressing application * Exposed bone in target wound * Exposed blood vessels or nerves in target wound * Systemic infection and/or systemic inflammatory response syndrome (SIRS), sepsis * Cellulitis in target wound * Untreated deep tissue infection including but not limited to osteomyelitis, septic arthritis * Active Pregnancy * Subjects that in the opinion of the investigator are not suitable for enrollment * Vulnerable subjects as determined by ICH Harmonized Guideline, Good Clinical Practice E6(R2)
Where it's running
-
ConvaCare Clinic
Santiago, Santiago Metropolitan, Chile Recruiting -
Middlewood Partnership
Bollington, Cheshire, United Kingdom Recruiting -
Knutsford Medical Partnership
Knutsford, Cheshire, United Kingdom Recruiting -
Dorset County Hospital NHS Foundation Trust
Dorchester, Dorset, United Kingdom Recruiting -
Assured Clinical Research Ltd
Swaffham, Norfolk, United Kingdom Recruiting -
Northumbria Healthcare NHS Foundation Trust
Ashington, Northumberland, United Kingdom Recruiting
Show 1 more location
-
Nottingham University Hospitals NHS Trust
Nottingham, Nottinghamshire, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Human placental membrane products plus standard care for nonhealing diabetic foot and venous leg ulcers
This trial will try human placental membrane products together with standard wound care to help adults whose diabetic foot ulcers or venous leg ulcers have not healed.
-
Photobiomodulation plus compression for venous leg ulcers
This trial tests whether adding photobiomodulation to standard compression therapy helps healing venous leg ulcers.
-
TrophiPatch cell patch for chronic diabetic and venous leg ulcers
We will try a one-time donor-derived adipose stromal cell patch (TrophiPatch) to help heal chronic diabetic foot or venous leg ulcers in adults.
-
Reducing skin tone inequities in chronic venous insufficiency care
This project will try ways to recognize and document leg skin changes in people with darker skin tones who have chronic venous insufficiency.
-
Evaluating Oxygen Therapy for Chronic Venous Leg Ulcers
This study is testing if a new oxygen therapy can help heal chronic venous leg ulcers better than standard treatment in people who have these wounds.
-
Evaluating how long venous leg ulcers stay closed after treatment
This study is testing how long venous leg ulcers stay closed after treatment with a special fish skin graft compared to standard care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.